story of the week
Ocrelizumab Therapy and Brain Volume Loss in Patients With Relapsing MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging
Mult. Scler. 2023 May 01;29(6)741-747, S Kolind, L Gaetano, HE Assemlal, C Bernasconi, U Bonati, C Elliott, N Hagenbuch, S Magon, DL Arnold, A TraboulseeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.